Over 8. 000 patienter (hoftefraktur: n=1711; hoftealloplastik: n=5829; større knæoperationer: n=1367) blev inkluderet i kontrollerede kliniske fase II - og III- studier.
Over 8,000 patients (hip fracture – 1,711, hip replacement – 5,829, major knee surgery – 1,367) were studied in controlled Phase II and III clinical studies.